Akura Medical: Valuation, Funding & Investors
Akura Medical is a medical technology company dedicated to addressing venous thromboembolism (VTE). Their flagship product, the Katana Thrombectomy System, aims to redefine pulmonary embolism treatment standards by enabling efficient removal of diverse clot types. Akura Medical is committed to reshaping the landscape of VTE care and making a lasting impact on patient lives worldwide.
Leadership & Board
- Current Number of Employees
- 42
- Current LinkedIn Followers
- 4,143
Latest Estimated Valuation
- Total Amount Raised
- $53M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $53M
- Latest Funding Round
- Series C
Employee Trend
Akura Medical had 42 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Akura Medical had 4,143 followers as of November 16, 2026. The number of followers increased by 29 (0.70%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Dec 01, 2025 | Series C | $53.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Qatar Investment Authority | Series C |
Similar Companies
A snapshot of private companies similar to Akura Medical, helping you discover and navigate related company profiles.








